Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,548 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma.
Saitta C, Garofano G, Afari JA, Tanaka H, Patil D, Yuen KL, Wang L, Cortes J, Meagher MF, Puri D, Cerrato C, Nguyen MV, Hakimi K, Kobayashi M, Fukuda S, Paciotti M, Lazzeri M, Lughezzani G, Buffi NM, Fujii Y, Master V, Derweesh IH. Saitta C, et al. Among authors: fujii y. Clin Genitourin Cancer. 2024 Dec;22(6):102232. doi: 10.1016/j.clgc.2024.102232. Epub 2024 Oct 11. Clin Genitourin Cancer. 2024. PMID: 39481317
Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
Tanaka H, Yoshida S, Komai Y, Sakai Y, Urakami S, Yuasa T, Yamamoto S, Masuda H, Koizumi M, Kohno A, Fukui I, Yonese J, Fujii Y, Kihara K. Tanaka H, et al. Among authors: fujii y. Urol Int. 2016;96(1):65-72. doi: 10.1159/000381269. Epub 2015 Jun 4. Urol Int. 2016. PMID: 26044598
Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma.
Kobayashi M, Tanaka H, Tateishi U, Numao N, Yonese J, Ito M, Koga F, Fukushima H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Kobayashi M, et al. Among authors: fujii y. Int J Urol. 2019 Aug;26(8):820-826. doi: 10.1111/iju.14022. Epub 2019 May 28. Int J Urol. 2019. PMID: 31140215
Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy.
Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Kijima T, et al. Among authors: fujii y. Clin Genitourin Cancer. 2020 Aug;18(4):268-273.e2. doi: 10.1016/j.clgc.2019.11.005. Epub 2019 Dec 4. Clin Genitourin Cancer. 2020. PMID: 31883941
Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Fukushima H, et al. Among authors: fujii y. Clin Genitourin Cancer. 2020 Apr;18(2):111-116.e1. doi: 10.1016/j.clgc.2019.10.027. Epub 2019 Nov 6. Clin Genitourin Cancer. 2020. PMID: 32001181
4,548 results